Category: Feature

A Look at SWOG’s Impact

Because answers to cancers come from clinical trials Since 1956, more than 200,000 participants have enrolled in SWOG-led studies; the resulting advancements in treatment and prevention have improved the lives of millions more. Why Cancer Clinical Trials? from The Hope Foundation on Vimeo. More about the group: SWOG has roughly 5,000 affiliated physician researchers – along …

Our Mission, Leaders, and Programs: A Video Overview

SWOG and The Hope Foundation pursue cancer research through collaboration, despite the fact that Group members, leadership and staff are based in locations all over the United States and beyond. Founded in 1993 by SWOG leaders, The Hope Foundation has granted more than $30 million in charitable funding to support the important work of the …

Preliminary Results of Foundation-Supported Project Presented at Group Meeting

Omar Aljitawi, MD, of the University of Kansas Cancer Center, has been researching a method to shorten the duration of neutropenia following stem cell transplantation, a standard-of-care procedure which accompanies high-dose chemotherapy for treatment of multiple blood cancers. Neutropenia invariably occurs following high-dose chemotherapy and resolves when the newly infused hematopoietic stem cells home to …

Foundation Support for 2015 Group Meetings

This is an archived news post. To see current meetings program detail, click here. — Each spring and fall,  SWOG holds Group Meetings to share trial results and review progress, conduct Group business, provide educational programming for member oncology professionals, and determine future research directions. The Hope Foundation has been helping to support SWOG Group Meetings for …

Goldberg and Unger Named Coltman Fellows

Sarah Goldberg, MD, of the Yale Cancer Center, and Joseph Unger, PhD, of the Fred Hutchinson Cancer Research Center, have been awarded Coltman Fellowships from The Hope Foundation. Goldberg’s fellowship will support her investigation of treatment for advanced non-small cell lung cancer. She was previously named a SWOG Young Investigator in 2013. Unger will utilize …

New Opportunities for SWOG, and More to Come

Greetings, Amidst the end-of-year onslaught of well deserving messages, it’s hard to make space for yet another one…I am doing so because SWOG research and your research matters. It matters for patients, for the research community, and for the notable progress in cancer treatment and prevention led by Network Group trials.  It’s been a busy …

Dana Sparks Celebrates 25th Year with SWOG

Congratulations to  Dana B. Sparks, M.A.T., Director of Operations and Protocols, who celebrates 25 years with SWOG (and counting!) today. In honor of Dana’s achievement, we proudly share her retrospective. – When I first came to work at SWOG in December of 1989, I was hired as a Protocol Coordinator for the Breast, Lymphoma, Head …

A Look at SWOG Cost Coverage Analysis

A Twitter contact recently posted accolades for SWOG and its practice of Cost Coverage Analysis. This got us wondering what this process entails in the world of cancer clinical trials. We decided to question resident expert Casey Dawson, SWOG/SWOG-CTI Project Manager. The Hope Foundation: What is Coverage Analysis? Casey Dawson: Coverage Analysis is a process …

Michael LeBlanc, PhD
Group Statistician

Updates, Right To Your Inbox

JOIN OUR EMAIL LIST

Find Us on Twitter

Johanna Horn, President & CEO

Give to a cause with proven resultsHope Works For Us All